James Lake
Primary Care · Kinston, NCNPI 1124704796
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations.
Across 138 payments — averaging $15.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$455
- Amgen$245
- Novo Nordisk$231
- Lilly USA, LLC$203
- Novartis$162
- GSK$116
- plus $757 from 18 others
What the payments were for
- Food & beverage$2,169100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 27 | $455 |
| Amgen | 18 | $245 |
| Novo Nordisk | 14 | $231 |
| Lilly USA, LLC | 15 | $203 |
| Novartis | 10 | $162 |
| GSK | 6 | $116 |
| Phathom Pharmaceuticals, Inc. | 6 | $90 |
| Boehringer Ingelheim | 5 | $77 |
| AstraZeneca | 5 | $75 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $69 |
| Merck | 4 | $63 |
| Exact Sciences | 4 | $63 |
| Eisai Inc. | 3 | $50 |
| Pfizer | 2 | $39 |
| AbbVie | 2 | $37 |
| Ardelyx, Inc. | 2 | $36 |
| ANI Pharmaceuticals, Inc. | 2 | $31 |
| Mylan Specialty L.p. | 2 | $28 |
| Abbott | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $15 |
How this compares
$2,169 in reported general payments places this provider in the 80th percentile of 236 primary care providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 15 | $404 |
| Potassium Chloride | 17 | $280 |
| Amlodipine Besylate | 54 | $190 |
| Baclofen | 23 | $183 |
| Levothyroxine Sodium | 17 | $175 |
| Fluticasone Propionate | 18 | $174 |
| Gabapentin | 11 | $132 |
| Atorvastatin Calcium | 27 | $125 |
| Azithromycin | 28 | $123 |
| Omeprazole | 13 | $106 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 18 | $106 |
| Metoprolol Succinate | 15 | $98 |
| Rosuvastatin Calcium | 14 | $98 |
| Cephalexin | 14 | $77 |
| Lisinopril | 16 | $33 |
Paid to pharmacies, not to this prescriber.
Other primary care in Kinston
- Jessica AllynRaleigh$21K
- Jennifer RogersWinston Salem$17K
- Elizabeth WaltersChapel Hill$14K
- Ragan JohnsonChapel Hill$13K
- Kirkland DickeyPine Hall$11K
- Kimberly WeaverHickory$9K
- Amanda StoneWilmington$9K
- Elizabeth WalshGreensboro$7K
- Mark HollingsworthWilmington$7K
- Crystal GoinsFayetteville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.